2m 2m 2m 2m 2m 2m 2m
ENTRADA THERAPET (TRDA)
NASDAQ
$6.58-$0.06 (-0.90%)
Price as of Jun 03, 2026 4:10 PM EDT- $274.5MMarket Cap
- -19.42%1-Year Change
- BiotechnologyIndustry
ENTRADA THERAPET (TRDA)
$6.58-$0.06 (-0.90%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 25.4M -87.94% | 210.8M +63.38% | 129.0M N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 25.4M -87.94% | 210.8M +63.38% | 129.0M N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -142.3M +13.54% | -125.3M +25.45% | -99.9M +49.96% | -66.6M +85.41% | |
Depreciation and Amortization Expense | 4.1M +8.56% | 3.8M +32.81% | 2.8M +49.92% | 1.9M +69.65% | |
Total Operating Expenses | 183.3M +11.94% | 163.8M +23.90% | 132.2M +35.92% | 97.2M +90.21% | |
Operating Profit | -157.9M -435.87% | 47.0M +1,586.75% | -3.2M -96.75% | -97.2M +90.21% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 15.1M -22.60% | 19.5M +27.97% | 15.2M +478.19% | 2.6M +8,590.32% | |
Income before Taxes | -142.8M -314.82% | 66.5M +451.47% | 12.1M +112.40% | -97.2M +90.21% | |
Income Taxes | 924,000 +7.57% | 859,000 -95.42% | 18.7M N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -143.8M -319.04% | 65.6M +1,081.69% | -6.7M -92.93% | -94.6M +84.95% | |
Net Income from Continuing Operations Applicable to Common | -143.8M -319.04% | 65.6M +1,081.69% | -6.7M -92.93% | -94.6M +84.95% | |
Basic EPS and Net Income | -3.47 -297.16% | 1.76 +980.00% | -0.20 -93.38% | -3.02 -62.99% | |
Diluted EPS and Net Income | -3.47 -306.55% | 1.68 +940.00% | -0.20 -93.38% | -3.02 -62.99% | |
Basic Weighted Average Shares | 41.4M +10.90% | 37.3M +12.88% | 33.1M +5.61% | 31.3M +399.27% | |
Diluted Weighted Average Shares | 41.4M +6.07% | 39.0M +18.01% | 33.1M +5.61% | 31.3M +399.27% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 90.4M -10.69% | 101.2M +49.72% | 67.6M +49.70% | 45.2M -84.49% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 90.4M -10.69% | 101.2M +49.72% | 67.6M +49.70% | 45.2M -84.49% | |
Total Current Assets | 306.3M -30.40% | 440.0M +19.00% | 369.8M +76.19% | 209.9M -29.74% | |
Accumulated Depreciation | 9.9M +5.41% | 9.4M +59.11% | 5.9M +79.43% | 3.3M +133.12% | |
Property and Plant and Equipment and Net | 7.3M -33.08% | 10.9M -2.35% | 11.2M +45.70% | 7.7M +22.68% | |
Total Long-Term Assets | 70,000 -75.35% | 284,000 -89.82% | 2.8M -46.45% | 5.2M +497.48% | |
Total Assets | 377.4M -28.30% | 526.3M +12.18% | 469.2M +86.15% | 252.1M -17.58% | |
Income Taxes Payable | 0 -100.00% | 667,000 -83.42% | 4.0M N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 24.5M -38.07% | 39.5M -75.14% | 158.8M +622.72% | 22.0M +227.01% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 46.8M -9.40% | 51.6M -14.38% | 60.3M +236.50% | 17.9M +4,426.77% | |
Total Liabilities | 71.2M -27.04% | 97.6M -56.95% | 226.8M +474.23% | 39.5M +455.19% | |
Retained Earnings | -273.1M +111.14% | -129.3M -33.66% | -195.0M +3.55% | -188.3M +101.01% | |
Total Stockholders Equity | 306.1M -28.59% | 428.7M +76.88% | 242.4M +14.02% | 212.6M -28.84% | |
Total Shares Outstanding | 38.3M +1.89% | 37.6M +12.37% | 33.4M +6.51% | 31.4M +0.55% | |
Cash Flow | |||||
Cash from Operating Activities | -128.5M +209.24% | -41.6M -129.73% | 139.8M +249.07% | -93.8M +84.39% | |
Capital Expenditures | 1.0M -67.04% | 3.2M -43.75% | 5.6M +94.46% | 2.9M -36.97% | |
Cash from Investing Activities | 116.8M +520.20% | -27.8M -79.91% | -138.4M -6.90% | -148.7M +3,145.63% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 887,000 -99.14% | 103.0M +389.44% | 21.0M +4,291.86% | 479,000 -99.84% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -621.13% -2,884.96% | 22.30% +1,010.00% | -2.45% N/A | N/A N/A | |
Return on Assets | -31.81% -341.30% | 13.18% +811.25% | -1.85% -94.53% | -33.92% N/A | |
Return on Equity | -39.13% -300.03% | 19.56% +765.52% | -2.94% -92.06% | -37.01% N/A | |
Revenue Growth | -87.94% -238.75% | 63.38% N/A | N/A N/A | N/A N/A | |
Current Ratio | 12.53 +12.38% | 11.15 +378.63% | 2.33 -75.62% | 9.55 N/A | |
Cash Ratio | 3.70 +44.21% | 2.56 +502.18% | 0.43 -79.29% | 2.06 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow